
IPCA Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2024, titled "Press Release w.r.t Technology Transfer to Omexa Formulary Pvt. Ltd. for development of an anti-cancer biosimilar for global market".
Filed with NSE ·

IPCA Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2024, titled "Press Release w.r.t Technology Transfer to Omexa Formulary Pvt. Ltd. for development of an anti-cancer biosimilar for global market".
6ix hasn’t read this filing yet.
IPCA Laboratories Limited on 6ix
Follow IPCA Laboratories into a list and get an email when it puts out news.
Follow IPCA Laboratories